Tauriga Sciences Stock Return On Equity
Tauriga Sciences fundamentals help investors to digest information that contributes to Tauriga Sciences' financial success or failures. It also enables traders to predict the movement of Tauriga OTC Stock. The fundamental analysis module provides a way to measure Tauriga Sciences' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Tauriga Sciences otc stock.
Tauriga |
Tauriga Sciences OTC Stock Return On Equity Analysis
Tauriga Sciences' Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Tauriga Sciences Return On Equity | -63.19 |
Most of Tauriga Sciences' fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Tauriga Sciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
CompetitionBased on the latest financial disclosure, Tauriga Sciences has a Return On Equity of -63.1922. This is 163.63% higher than that of the Healthcare sector and significantly lower than that of the Drug Manufacturers—Specialty & Generic industry. The return on equity for all United States stocks is notably higher than that of the company.
Tauriga Return On Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Tauriga Sciences' direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Tauriga Sciences could also be used in its relative valuation, which is a method of valuing Tauriga Sciences by comparing valuation metrics of similar companies.Tauriga Sciences is currently under evaluation in return on equity category among its peers.
Tauriga Fundamentals
| Return On Equity | -63.19 | |||
| Return On Asset | -1.72 | |||
| Operating Margin | (17.15) % | |||
| Current Valuation | 519.42 K | |||
| Shares Outstanding | 299.91 M | |||
| Shares Owned By Insiders | 3.38 % | |||
| Price To Earning | 1.82 X | |||
| Price To Book | 6.60 X | |||
| Price To Sales | 0 X | |||
| Revenue | 285.32 K | |||
| Gross Profit | 122.69 K | |||
| EBITDA | (2.53 M) | |||
| Net Income | (3.63 M) | |||
| Cash And Equivalents | 1.02 M | |||
| Total Debt | 1.51 M | |||
| Debt To Equity | 0.85 % | |||
| Current Ratio | 0.68 X | |||
| Book Value Per Share | (0) X | |||
| Cash Flow From Operations | (2.55 M) | |||
| Earnings Per Share | (0.02) X | |||
| Target Price | 0.1 | |||
| Beta | 1.94 | |||
| Market Capitalization | 299 | |||
| Total Asset | 2.49 M | |||
| Retained Earnings | (53.26 M) | |||
| Working Capital | (2.96 M) | |||
| Current Liabilities | 2.96 M | |||
| Z Score | -33.9 | |||
| Net Asset | 2.49 M |
About Tauriga Sciences Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Tauriga Sciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Tauriga Sciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Tauriga Sciences based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in employment. You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Other Consideration for investing in Tauriga OTC Stock
If you are still planning to invest in Tauriga Sciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Tauriga Sciences' history and understand the potential risks before investing.
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities |